首页产品供求市场行情现货直销公司信息
产品
产品 公司 求购 资讯 法规
English
  1. 您当前位置：
  2. 首页
  3. 产品数据
  4. 二甲基二硫代氨基甲酸锌

二甲基二硫代氨基甲酸锌

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 上游产品
  • 下游产品
  • 表征图谱

二甲基二硫代氨基甲酸锌 基本信息

中文名称：
二甲基二硫代氨基甲酸锌 
中文别名：
福美锌;
双-(二甲基硫代氨基甲酸)锌;
二甲基二硫代氨基甲酸锌 
英文名称：
Zinc,bis(N,N-dimethylcarbamodithioato-kS,kS')-, (T-4)-
英文别名：
Zinc, bis(N,N-dimethylcarbamodithioato-κS,κS')-, (T-4)-;
Zinc, bis(dimethylcarbamodithioato-S,S')-, (T-4)-;
Zinc, bis(dimethylcarbamodithioato-κS,κS')-, (T-4)- (9CI);
Zinc, bis(dimethyldithiocarbamato)- (8CI);
(T-4)-Bis(N,N-dimethylcarbamodithioato-κS,κS')zinc;
Carbamodithioic acid, dimethyl-, zinc complex;
Aaprotect;
Aavolex;
Aazira;
Accel PZ;
Accelerator L;
Accelerator MZ Powder;
Accelerator MZX;
Accelerator PZ;
Aceto ZDED;
Aceto ZDMD;
Alcobam ZM;
Ancazate ME;
Bis(dimethyldithiocarbamato)zinc;
Carbamodithioic acid, dimethyl-, zinc salt;
Carbazinc;
Corona Corozate;
Corozate;
Crittam;
Cuman;
Cuman L;
Cymate;
Eptac 1;
Fuclasin;
Fuclasin-Ultra;
Fuklasin;
Fulasin;
Hermat ZDM;
Hexazir;
Karbam White;
Methasan;
Methazate;
Methyl Ziram;
Methyl zimate;
Methyl zineb;
Mezene;
Milbam;
Molurame;
Mycronil;
NSC 737;
Nocceler PZ;
Octocure ZDM 50;
Orchard brand Ziram;
PZ;
Perkacit ZDMC;
Pomarzol Z-forte;
Rhenogran ZDMC 80;
Rhodiacid;
Rodisan;
Sanceler PZ;
Soxinal PZ;
Soxinol PZ;
Trikagol;
Ultra Zinc DMC;
Vancide MZ 96;
Vulcacure ZM;
Vulkacit L;
Vulkacite L;
Z 75;
Z-C Spray;
ZDMC;
ZDMC 80;
Zarlate;
Zerlate;
Zimate;
Zinc bis(dimethyldithiocarbamate);
Zinc dimethyldithiocarbamate;
Ziradin;
Ziram;
Zirberk;
Ziride;
Zirol;
Zirthane;
ZnMDC 
CAS No.：
137-30-4
分 子 式：

C6H12N2S4Zn

分 子 量：
305.80
精确分子量：
303.91748
PSA：
121.26000
MDL：
MFCD00064797
EINECS：
205-288-3
BRN：
3707008
InChI：
InChI=1/2C3H7NS2.Zn/c2*1-4(2)3(5)6;/h2*1-2H3,(H,5,6);/q;;+2/p-2/rC6H12N2S4Zn/c1-7(2)5(9)11-13-12-6(10)8(3)4/h1-4H3
危险品标志：

风险术语：

R22;R26;R37;R41;R48/22;R50/53;

安全术语：

S22;S26;S28;S36/37/39;S45;S60;S61;

分子结构式：
SDS：
查看

二甲基二硫代氨基甲酸锌 制备方法及用途

制备方法

(1)二甲基二硫代氨基甲酸钠的制备先将固碱在反应釜内配成15%的水溶液,再加入二硫化碳和二甲胺,搅拌下微微加热,保持温度于40～45℃,进行缩合反应1h以上。至体系pH值为9～10时,所得浅黄绿色或琥珀色液,即为二甲基二硫代氨基甲酸钠。 (2)促进剂PZ的制备在上述制得的二甲基二硫代氨基甲酸钠中加入硫酸锌或氯化锌,搅拌下控制温度于30℃以下,进行复分解反应。反应产物经过滤、干燥、粉碎、筛选,即得成品。 3.由福美钠加水溶解,用稀酸调整反应液pH值为7.5～8,然后与硫酸锌作用,生成福美锌沉淀,经过滤、干燥、粉碎制得福美锌原药。收率>97%,含量≥93%。

合成制备方法

（1）二甲基二硫代氨基甲酸钠的制备先将固碱在反应釜内配成15%的水溶液，再加入二硫化碳和二甲胺，搅拌下微微加热，保持温度于40～45℃，进行缩合反应1h以上。至体系pH值为9～10时，所得浅黄绿色或琥珀色液，即为二甲基二硫代氨基甲酸钠。


（2）促进剂PZ的制备在上述制得的二甲基二硫代氨基甲酸钠中加入硫酸锌或氯化锌，搅拌下控制温度于30℃以下，进行复分解反应。反应产物经过滤、干燥、粉碎、筛选，即得成品。

3.由福美钠加水溶解，用稀酸调整反应液pH值为7.5～8，然后与硫酸锌作用，生成福美锌沉淀，经过滤、干燥、粉碎制得福美锌原药。收率＞97%，含量≥93%。

用途简介

ZDMC是应用于NR，lR，SBR，NBR，llR，和EPDM主促进剂或助促进剂。硫化速度比TMTD快，有很好的抗焦性。很少单独用，通常作为助促进剂。硫化温度低，硫化速度快。为安全生产，通常需和噻唑类促进剂并用。本品无味无毒，可以用于制造与食品接触的橡胶制品。

用途

1.本品用作天然橡胶、合成橡胶及胶乳的一般促进剂。特别适用于丁基胶和丁腈胶，也适用于三元乙丙胶。硫化温度约100℃，活性与促进剂TMTD相近，但低温时活性较强，焦烧倾向大，混炼时易引起早期硫化。本品对噻唑类、次磺酰胺类促进剂有活化作用，可作第二促进剂。与促进剂DM并用时，随DM的用量增加抗焦烧性能也增加。本品在乳胶中单独使用时硫化速度较慢，通常与其他促进剂并用。本品在橡胶中易分散，适用于浅色和艳色制品。主要用于胶乳制品，也可用于自硫化胶浆、胶布、冷硫化制品。在美国，PZ已得到食品药品管理局（FDA）的批准，可用于食品用橡胶制品。在胶乳胶料中一般用量为0.3～1.5份。

2.保护性杀菌剂。对多种真菌引起病害有抑制和预防作用，兼有刺激生长、促进早熟的作用。用于防治水稻稻瘟病、恶苗病，麦类锈病、白粉病，马铃薯晚疫病、黑斑病，黄瓜、白菜、甘蓝霜霉病，番茄炭疽病、早疫病，瓜类炭疽病，烟草立枯病，苹果花腐病、炭疽病、黑点病、赤星病，葡萄白粉病、炭疽病，梨黑星病，柑橘溃疡病、疮痂病等。一般用65%可湿性粉剂300～500倍液处理。发病前或初期喷洒，有预防作用，发病期每隔5～7d喷雾1次，连续2～4次。根据不同病害，用药量和用药次数不同。

二甲基二硫代氨基甲酸锌 物化性质

外观与性状：
白色至灰白色粉末
密度：
1.66
熔点：
248-257ºC
闪点：
93ºC
水溶解性：
0.0065 g/100 mL
存储条件/存储方法：

内衬塑料袋，外用聚丙烯编织袋包装，置于通风干燥处，储存稳定期为两年。

稳定性相关：

无毒、无味。从热氯仿或乙醇中得到的结晶，几乎不溶于水和汽油，但在水中有良好的润湿性。

其它信息：

1. 性状：白色或浅黄色粉末。无毒、无味。

2.相对密度：2.00

3. 熔点（ºC）：250

4. 溶解性；溶于氯仿、氨水、二硫化碳及稀碱液，微溶于水、乙醇和乙醚。

 

二甲基二硫代氨基甲酸锌 安全信息

包装等级：
I; II; III
风险类别：
6.1
海关代码：
2930200090
危险类别码：
R22;R26;R37;R41;R48/22;R50/53
安全说明：
S22-S26-S28-S36/37/39-S45-S60-S61
安全标志：
S22:不要吸入粉尘。
S26:万一接触眼睛，立即使用大量清水冲洗并送医诊治。
S28:接触皮肤之后，立即使用大量皂液洗涤。
S45:出现意外或者感到不适，立刻到医生那里寻求帮助（最好带去产品容器标签）。
S60:本物质残余物和容器必须作为危险废物处理。
S61:避免排放到环境中。参考专门的说明/安全数据表。
:
危险标志：
T+:Verytoxic;N:Dangerous for the environment;

二甲基二硫代氨基甲酸锌 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
ZH0525000
CHEMICAL NAME :
Zinc, bis(dimethyldithiocarbamato)-
CAS REGISTRY NUMBER :
137-30-4
LAST UPDATED :
199710
DATA ITEMS CITED :
63
MOLECULAR FORMULA :
C6-H12-N2-S4.Zn
MOLECULAR WEIGHT :
305.81
WISWESSER LINE NOTATION :
1N1&YUS&S-ZN-SYUS&N1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
267 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
81 mg/m3/4H
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>6 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
8700 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
69 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1230 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
480 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - changes in motor activity (specific assay)
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1056 mg/m3/2H
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - corneal damage Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
15500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
309 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Behavioral - coma
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Behavioral - coma
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
1400 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Bird - wild bird species
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
80080 mg/kg/2Y-C
TOXIC EFFECTS :
Behavioral - food intake (animal) Endocrine - changes in spleen weight Endocrine - changes in thyroid weight
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
45 gm/kg/30D-C
TOXIC EFFECTS :
Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
770 mg/kg/4W-C
TOXIC EFFECTS :
Liver - changes in liver weight Endocrine - changes in spleen weight Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
5 mg/m3/4H/17W-I
TOXIC EFFECTS :
Blood - normocytic anemia Blood - changes in erythrocyte (RBC) count Blood - changes in leukocyte (WBC) count
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
9125 mg/kg/1Y-C
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
28 mg/kg/4W-C
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
3640 mg/kg/2Y-C
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
12978 mg/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Endocrine - thyroid tumors Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Implant
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
60 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Liver - tumors Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
840 mg/kg/13W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Lungs, Thorax, or Respiration - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
25956 mg/kg/2Y-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Endocrine - thyroid tumors Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
13160 mg/kg/94W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
500 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
250 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
1 gm/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - cardiovascular (circulatory) system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
500 mg/kg
SEX/DURATION :
female 6-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea)
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Sex chromosome loss and nondisjunction
TYPE OF TEST :
DNA damage
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
Cytogenetic analysis

MUTATION DATA

TYPE OF TEST :
Sister chromatid exchange
TEST SYSTEM :
Rodent - hamster Ovary
DOSE/DURATION :
25 ug/L
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 13,133,1989 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,423,1991 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,259,1976 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 12,259,1976 IARC Cancer Review:Human No Available Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,423,1991 IARC Cancer Review:Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 53,423,1991 *** U.S. STANDARDS AND REGULATIONS *** EPA FIFRA 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION FEREAC Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) V.1- 1936- Volume(issue)/page/year: 54,7740,1989 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80305 No. of Facilities: 267 (estimated) No. of Industries: 5 No. of Occupations: 27 No. of Employees: 3838 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80305 No. of Facilities: 2044 (estimated) No. of Industries: 20 No. of Occupations: 23 No. of Employees: 34594 (estimated) No. of Female Employees: 5542 (estimated)
毒理学数据：

大鼠急性经口LD50为1400mg/kg，对皮肤、鼻黏膜及喉头有刺激作用，断奶的鼠以含100mg/kg的饲料饲喂30d和以每天5mg/kg剂量喂狗一年，均无不良反应。鲤鱼LC50为0.075mg/L（48h）。

二甲基二硫代氨基甲酸锌 MSDS

第一部分：化学品名称

二甲基二硫代氨基甲酸锌 海关数据

中国海关编码：2930200090

概述：
2930200090 其他硫代氨基甲酸盐或酯（包括二硫代氨基甲酸盐）。监管条件:无。增值税率:17.0%。退税率:9.0%。最惠国关税:6.5%。普通关税:30.0%
申报要素：
品名, 成分含量, 用途
摘要/Summary：
2930200090 other thiocarbamates and dithiocarbamates。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

二甲基二硫代氨基甲酸锌 分子结构与计算化学数据

计算化学数据

1.疏水参数计算参考值（XlogP）:无

2.氢键供体数量:0

3.氢键受体数量:4

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积72.7

7.重原子数量:13

8.表面电荷:0

9.复杂度:54.3

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:3

二甲基二硫代氨基甲酸锌 上游产品

氯化锌 二甲氨基二硫代甲酸钠 福美双 锌 二硫化碳

二甲基二硫代氨基甲酸锌 下游产品

CAS号：75642-17-0 辛酸锌 硬脂酸锌 锌壬烷-1-酸盐 庚酸锌

二甲基二硫代氨基甲酸锌 表征图谱

推荐供应商更多供应商>>

@2009-2024 洛克化工网 浙ICP备16009103号 版权声明